Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes

about

Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes

Item

http://www.wikidata.org/entity/Q58712651

description

scientific article published on 23 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@en

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@nl

type

Item

label

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@en

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@nl

prefLabel

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@en

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@nl

P1476

Switching From Glargine to Deg ...... olescents With Type 1 Diabetes

@en

P2093

Giulio Maltoni

http://www.w3.org/2001/XMLSchema#string

Lorenzo Iughetti

http://www.w3.org/2001/XMLSchema#string

Patrizia Bruzzi

http://www.w3.org/2001/XMLSchema#string

Stefano Zucchini

http://www.w3.org/2001/XMLSchema#string

Tosca Suprani

http://www.w3.org/2001/XMLSchema#string

Vanna Graziani

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Assessing fear of hypoglycemia in children with Type 1 diabetes and their parents

Assessment and management of hypoglycemia in children and adolescents with diabetes.

Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review

Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study.

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

Basal insulin requirement of youth with type 1 diabetes differs according to age.

A review of the pharmacological properties of insulin degludec and their clinical relevance.

Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.

P304

462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2018.00462

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Predieri

P577

2018-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30190702

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

teenager

P932

6115523

http://www.w3.org/2001/XMLSchema#string